Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Drops By 96.1%

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totaling 927 shares, a decrease of 96.1% from the March 15th total of 23,692 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 31,866 shares, the short-interest ratio is currently 0.0 days.

Arcadia Biosciences Stock Down 1.5%

RKDA traded down $0.02 during trading on Friday, reaching $1.32. 35,505 shares of the stock traded hands, compared to its average volume of 26,924. The stock has a market capitalization of $2.72 million, a PE ratio of -0.77 and a beta of 0.72. The stock’s 50-day moving average is $1.71 and its 200 day moving average is $2.77. Arcadia Biosciences has a 12 month low of $1.30 and a 12 month high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings data on Thursday, March 26th. The basic materials company reported ($0.98) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.32). Arcadia Biosciences had a positive return on equity of 37.36% and a negative net margin of 48.15%.The company had revenue of $0.90 million for the quarter, compared to the consensus estimate of $1.40 million.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision?breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.